Regulatory Science and Sustainable Implementation of National and International Medical Device Registries
|
|
- Emery Alexander
- 6 years ago
- Views:
Transcription
1 Regulatory Science and Sustainable Implementation of National and International Medical Device Registries Focus-- Cardiovascular Registries TAVR: Case Study on the Value of Collaboration Ralph Brindis, MD, MPH, MACC, FSCAI Senior Medical Officer, ACC-NCDR March 24, 2014
2 Disclosure Statement of Financial Interest Senior Medical Officer, External Affairs ACC- NCDR Salaried Position
3 The Goals of the TVT Registry Learn from patient-level data Regulatory device surveillance Quality improvement Insights into patient selection, etc. Feedback, benchmarking, and best practices at a site level Patient education and informed decision-making Research important hypotheses tested to expand our understanding Be a driving force in improving our health care system
4 All 14,210 Cases are Commercial TAVR 288 Sites Enrolled in TVT Registry 274 Sites Entering Data 6 Sites > 200 Cases; 24 Sites > 100 Cases Does Not Include All TAVR Cases in US Over 10K Cases from Trials Some Commercial TAVR Cases Before NCD, VA Cases
5 Sites Participating in TVT Registry (Currently TAVR) No TAVR sites in Alaska and Wyoming (currently patients served by Seattle and Colorado sites) 1. As of last week 288 TAVR sites fully enrolled. Additional sites being trained by Edwards and Medtronic will be added. 2. Approximately 43 sites have started commercial MitraClip use are already TAVR-TVT sites.
6 TVT Registry is a Major Collaborative Partnership ACC STS MEDICAL DEVICE Companies FDA TVT Registry DCRI CMS NHLBI ATS AND SCAI PATIENT ADVOCACY GROUPS
7 Governance Steering Committee Research and Publications Subcommittee Stakeholder Advisory Group Data Monitoring Group
8 STS Members Fred Edwards Fred Grover Michael Mack Dave Shahian Steering Committee Ex Officio Members FDA - Danica Marinac-Dabic, John Laschinger CMS - Jyme Schafer NHLBI - Frank Evans Chair TVT R&P Subcommittee - John Rumsfeld DCRI Eric Peterson ACC Members Ralph Brindis John Carroll David Holmes Murat Tuzcu Registry Operations Center NCDR Data Analytics Center DCRI Staff Cynthia Shewan, Tina Kourtis Joan Michaels, Kathleen Hewitt, Barb Christensen
9 STS Members Fred Edwards (Co- Chair) Research and Publications Steering Committee- Murat Tuzcu Committee ACC Members John Rumsfeld (Chair) Registry Operations Center NCDR Vinod Thourani David Cohen Jeffrey Jacobs Neal Kleiman Todd Dewey Ajay Kirtane Staff Ex Officio Members Cynthia Shewan FDA Art Sedrakyan Mary Weideman Biostats - Eugene Joan Michaels Blackstone Kathleen Hewitt DCRI Eric Peterson Data Analytics Center DCRI, Eric Peterson
10 STAKEHOLDER ADVISORY GROUP Society Representatives John Carroll, MD TVT Registry Steering Committee liaison Larry Dean, MD SCAI Joseph Bavaria, MD AATS Consumer Representatives Bray Patrick-Lake PFO Research Foundation John Santa, MD Consumer Reports Fmr. Rep. Tony Coelho Public Member Health System and Health Plans Robert Guyton, MD Chair STS Representative Eric Bates, MD Vice-Chair ACC Representative Tom Priselac Cedars-Sinai Hospital System Industry Representatives Chuck Simonton, MD Abbott Vascular Larry Wood Edwards Lifesciences Nusrath Sultana, MD St. Jude Medical Tom Armitage, MD Medtronic Keith Dawkins, MD Boston Scientific Government Representatives Bram Zuckerman, MD FDA liaison John Laschinger, MD FDA liaison Danica Marinac-Dabic, MD FDA liaison Marissa Miller, DVM NIH liaison Marie Casey CMS liaison Society Staff Representatives Cynthia Shewan STS and Joan Michaels ACC
11 July 2011 Nov 2011 Dec 2011 May 2012 Feb 2013 Sept 2013 Oct 25, 2013 Jan 17, 2014 May 18, 2014 May 2014 TVT Registry proposed at FDA Advisory Panel for Edwards Sapien Valve FDA Approves Edwards Sapien THV STS/ACC TVT Registry Launched Version 1.0 CMS issued National Coverage Decision STS/ACC TVT Registry Launched Version 1.2 STS/ACC TVT Registry Launched Version 1.3 FDA Approves Abbott MitraClip FDA Approves Medtronic CoreValve Anticipated Decision for NCD for MitraClip STS/ACC TVT Registry Launch for 2.0
12 Transcatheter Aortic Valve Replacement STS-ACC TVT Registry Three Modules in 2.0 Release Transcatheter Mitral Valve Repair Transcatheter Mitral Valve Replacement Types Native Valve-in-Valve Technologies Sapien TM CoreValve TM Types Direct Leaflet Technologies MitraClip TM Future Additions Annular Reduction Types Native Valve-in-Valve Valve-in-Ring Technologies Sapien TM Relevant Issues Commercially approved Melody TM valve in separate NCDR registry Potential Areas of Expansion in TVT Arena? Mitral balloon commissurotomy Para-prosthetic valve regurgitation repair with transcatheter plugs
13 STS Members TVT Registry Mitral Module Workgroup Composition ACC Members Fred Edwards John Carroll - Chair Patrick McCarthy Samir Kapadia Craig Miller Echo Specialists Paul Grayburn *** Neil Weissman Data Analytic Center (DCRI) FDA - John Laschinger*** STS, DCRI and ACC Staff Cynthia Shewan and Donna McDonald STS Michael Booth and Paul Meehan - DCRI Joan Michaels and Susan Fitzgerald ACC *** Heart Failure Specialists Maggie Redfield JoAnn Lindenfeld Stakeholders FDA CMS Industry ACC and STS leadership Analytic Centers Users (public comment period) Abbott Input Barathi Sethuraman Bhagya Gurusu Liz McDermott
14 Data Quality!!!! 1. Training and Clinical Support Team Orientation webinars Online FAQs Live customer support Monthly webinars Annual meeting with case reviews, etc. 2. Data Entry Integrity Software value checks Field level range parameters Parent:Child fields 3. Data Completeness Sites receive completeness reports to resubmit with missing fields completed predetermined levels of completeness and consistency required for data to be included in national and comparison group averages 4. Data Accuracy Up to 650 records are audited annually. 5. Adjudication of Adverse Events In the 2010 audits, the overall accuracy of data abstraction for the CathPCI, ICD, and ACTION-GWTG registries were, respectively, 93.1%, 91.2%, and 90.0%. JACC June, 2012
15 Adjudication Data Quality Program Post Submission Verifies and provides additional information for key events (stroke, TIA and repeat intervention, plus CHF admission for MitraClip) National audit program (starts in 2014) Evaluates accuracy and reliability Assesses proper and complete reporting of cases Voluntary and self audits Data Outlier Program Provides outlier alerts to Registry participants
16 Adjudication Process: Additional Data and Physician Review at DCRI
17 The FDA should develop a comprehensive medical device postmarket surveillance strategy to collect, analyze and act on medical device postmarket performance information
18 UDI system incorporated into EHR National and international device registries Modernize adverse event reporting New methods for evidence generation, synthesis and appraisal
19
20 Why Use Clinical Registries? Clinical registries currently offer the only data sources that include: Granular clinical data needed for risk-adjustment Medical device identifying information needed to capture specific exposure Detailed and relevant clinical outcomes Where Registries Fail Today: Limited scope capture of only specific devices and conditions Limited longitudinal follow-up
21 International Registry Participation Global Registry Participation Makes Sense Benefits U.S., Since Devices Come Here Last Harmonized Data Elements and Definitions So We All Speak the Same Language Identify Issues on a Larger Scale Identify Regional/National Differences in Practice, Performance, Outcomes Possible Role in U.S. Regulatory Process
22 THE FUTURE MODEL OF QUALITY MEASUREMENT AND POST MARKET SURVEILLANCE IS HERE! MDEpiNet FDA initiative Cornell/International Consortium of Cardiovascular Registries TVT initiative (ICCR- ICTVR) grant: Germany, France, Canada, United Kingdom, Netherlands, and Japan
23
24
25 Defining TVT Registry Collaboration Success Professional Society Goals: The TVT Registry should maintain the traditional goals of the professional societies: 1) Patient Care 2) education, 3) research, 4) members interests. Are the professional societies governing boards still supportive of the TVT Registry? Are other professional societies being included or do they feel excluded? Governance Goals: Does the present structure work? Leaders communicating well? Steering Committee decisions made appropriately? R & P and the Stakeholders Committees functioning well? Cost/Benefit Goal: The TVT Registry must provide benefits by meeting all goals and at a cost that can be considered reasonable, and ideally with an overall cost reduction. Scientific Integrity Goals: Objective, bias-free, and scientifically based reports? Is the TVT Registry in compliance of COI policies from the STS and ACC for members representing these entities?
26 Regulatory Goals New infrastructure for PAS and IDE studies Replacement of off-label use without data collection and lack of pathway to expand label indications. Leveraging costs and maximizing quantity of patient data Medical Device Surveillance Goal All implanted devices should be monitored with periodic assessments of expected device-related adverse events and identification of an unanticipated adverse events. Device Efficacy and Safety: Sharing of the responsibility by more than FDA and Industry. Public-Private Partnership- MDEpiNet
27 Medical Device Industry Goals: Does the medical industry view the TVT Registry as an improvement versus the prior system? What do they see as the benefits versus the losses/sacrifices? TBD Abbott Vascular Edwards Lifesciences St. Jude Medical Medtronic
28 Financial Goals Is the TVT Registry Financially Viable and Sustainable? Are We Under or Overestimating Costs? Are Professional Societies Using TVTR as Income stream to support their societies other missions? Is Industry Taking Advantage or Have We Created a More Cost- Effective Infrastructure for all? Are Costs Being Shifted to Hospitals, TVTR or CMS for Expanded Indications Studies?
29 TVT Registry Formula for Success: Working Collaboratively with FDA and CMS Realizing that we are all in the Same Boat Avoidance of Turf Wars STS & ACC holding hands ATS and SCAI collaboration Promotion of true transparency and blame free environment working towards solutions Communication, communication and communication Weekly scheduled steering committee calls Extemporaneous leadership calls Documentation, documentation and documentation
30 Key Alignment of CMS, Pre-Market and Post- Market FDA and the TVT Registry Truthfully- a continuous work in evolution Constant alignment of stakeholder s aims and goals Sensitivity and maintaining focus to hospital/clinician burden of data collection and costs Acknowledgement and sensitivity to Industry needs Issues of availability to patient level vs. aggregate data, timeliness, industry independent analytical capabilities, and their own regulatory needs Requirements for PMS, PAS and IDE studies Patient s needs and rights informed consent and IRB issues for both IDE and PAS studies
31 The Good New collaboration between many partners Capability for robust post market surveillance Expansion of the role of registries
32 The Bad Burdensome data collection for sites Initial and annual expense for sites Site agreements, contracts, informed consent Communication between all stakeholders is a constant challenge in uncharted waters!!
33 To Be Determined Different stakeholders have different goals FDA- safe and effective CMS- reasonable and necessary Professional Societies- appropriate use, guidelines Industry-post approval surveillance
34 The Potential Breadth of TVT Registry Pre-Market Phase 1 Phase 2 Phase 3 Post- Approval Post-Market Role for New Generation of Clinical Registries Phase 4 Post- Market Registries
Objectives. The Goals of the TVT Registry
STS/ACC TVT Registry From Beginning to Now Joan Michaels, RN, MSN, CPHQ, AACC March 27 2014 Objectives Discuss past and present STS/ACC TVT Registry activities Identify at least two benefits to participating
More informationObjectives. The Goals of the TVT Registry. STS/ACC TVT Registry Update March 27, John D. Carroll, MD TVT Registry Steering Committee Liaison
STS/ACC TVT Registry Update March 27, 2014 John D. Carroll, MD TVT Registry Steering Committee Liaison Objectives Provide an overview of past and present registry activities Demonstrate the benefits of
More informationACC State Chapters Best Practice Guide. Working with States on Clinical Data Requests
ACC State Chapters Best Practice Guide Working with States on Clinical Data Requests Prepared by: Science, Education and Quality Division As of: 3/16/2016 Contents 1. Introduction... 1 2. NCDR Registries
More informationDanica Marinac-Dabic, MD, PhD, MMSc, FISPE Director, Division of Epidemiology, FDA/CDRH MDEPINET INTERNATIONAL REGISTRY CONSORTIA, DATA AND MODELS
Danica Marinac-Dabic, MD, PhD, MMSc, FISPE Director, Division of Epidemiology, FDA/CDRH MDEPINET INTERNATIONAL REGISTRY CONSORTIA, DATA AND MODELS 1 2011 ICOR Inaugural Meeting at FDA American Joint Replacement
More informationSIMPLE SOLUTIONS. BIG IMPACT.
SIMPLE SOLUTIONS. BIG IMPACT. SIMPLE SOLUTIONS. BIG IMPACT. QUALITY IMPROVEMENT FOR INSTITUTIONS combines the American College of Cardiology s (ACC) proven quality improvement service solutions and its
More informationACTION Registry-GWTG. NCDR13 Updates 3/22/2013. ACTION Cumulative Records Submitted Q Q Q Q Q3 Records Submitted
ACTION Registry-GWTG NCDR13 Updates 500000 450000 400000 350000 300000 250000 200000 150000 100000 50000 0 ACTION Cumulative Records Submitted 457970 327168 219151 138117 83446 2008 Q3 2009 Q3 2010 Q3
More informationFDA Vision for Innovative Surveillance of Orthopedic Implants
FDA Vision for Innovative Surveillance of Orthopedic Implants Danica Marinac-Dabic, MD, PhD Director, CDRH Division of Epidemiology Head, FDA ICOR Initiative Total and Resurfacing Hip Systems: Post-Approval
More informationInvestigator s Guide to NCDR Research
Investigator s Guide to NCDR Research Table of Contents WELCOME... 4 OVERVIEW... 5 NCDR Data Registries... 5 NCDR Research... 5 NCDR Data Analytics... 5 Human Subject Research and the NCDR... 6 NCDR RESEARCH
More informationStrategies for an Effective Structural Heart Program: Current and Future Considerations
Strategies for an Effective Structural Heart Program: Current and Future Considerations Eric L. Sarin, MD Co-Director, Structural Heart and Valve Program Co-Director, Cardiovascular Research Inova Heart
More informationOn May 1, 2012, the Centers for Medicare & Coverage Decision. How will this recent announcement affect your patients and practice?
VALVE UPDATE The TAVR National Coverage Decision How will this recent announcement affect your patients and practice? Ted E. Feldman, MD, is Director of the Cardiac Catheterization Laboratory at Evanston
More informationSBAR: NCDR Registries Initiation and Feedback Phase
SBAR: NCDR Registries Initiation and Feedback Phase Title: NCDR Registries CECCV-36 Situation: Less than ~76% of TH procedure sites belong to NCDR Registries. Background: Registries ensure evidenced-based
More informationNCDR 13 Annual Conference. ACTION Registry-GWTG Workshop #1. Disclosures Dr. Fonarow, MD, FACC, FAHA. Objectives 2/28/2013.
NCDR 13 Annual Conference ACTION Registry-GWTG Workshop #1 Disclosures Dr. Fonarow, MD, FACC, FAHA Boston Scientific, Takeda, Amgen, Johnson&Johnson, Medtronic, Gambro, NIH/NIAID, Novartis, NHLBI Kim Hustler
More informationBetter Medical Device Data Yield Improved Care The benefits of a national evaluation system
A fact sheet from Aug 2016 Better Medical Device Data Yield Improved Care The benefits of a national evaluation system Overview The current system for evaluating implanted medical devices provides inadequate
More informationFinal Document. Title: Tools for Assessing the Usability of Registries in Support of Regulatory Decision-Making
Final Document Title: Tools for Assessing the Usability of Registries in Support of Regulatory Decision-Making Authoring Group: Patient Registries Working Group Date: 27 March 2018 Yuan Lin, IMDRF Chair
More informationStrengthening Patient Care: Building an Effective National Medical Device Surveillance System. February 2015
Strengthening Patient Care: Building an Effective National Medical Device Surveillance System February 2015 The Brookings Institution l Washington, DC www.brookings.edu Authors Gregory Daniel Managing
More informationCollaborative Communities: It Really Does Take a Village
Collaborative Communities: It Really Does Take a Village April 25 th Karen Conway, GHX Denise Downing, AORN Ellenmary Martin, Dukal Corp. Terrie Reed, FDA Linda Rouse-O Neill, HIDA Slide 1 Slide 2 2018
More informationPediatric Medical Devices: The FDA Postmarket Perspective
Pediatric Medical Devices: The FDA Postmarket Perspective Thomas P. Gross, MD, MPH Deputy Office Director Office of Surveillance and Biometrics Center for Devices and Radiological Health Pediatric Safety
More informationIntegrated Cardiovascular Care Private Practice Perspective
Integrated Cardiovascular Care Private Practice Perspective Florida Hospital Cardiovascular Institute Kevin Accola, M.D., F.A.C.S. CARDIOVASCULAR SURGEONS, P.A. Program Director, Valve Center of Excellence
More informationWorkshop #10: IMPACT Registry Data Quality Reports. Presenter Disclosure Information. Objectives 2/25/2013
Workshop #10: IMPACT Registry Data Quality Reports Presenter Disclosure Information Joanne Chisholm RN, BSN, CEN Joshua Kanter MD, FACC Kristina McCoy MSN, CPHQ, NP-C Joan Michaels RN, MSN, CPHQ The following
More information4/9/2016. The changing health care market THE CHANGING HEALTH CARE MARKET. CPAs & ADVISORS
CPAs & ADVISORS experience support // ADVANCED PAYMENT MODELS: CJR Eric. M. Rogers MEd. RT(R) Managing Consultant The changing health care market THE CHANGING HEALTH CARE MARKET HHS goal of 30% of traditional
More informationMOC Part IV: Your Guide to Making it Happen.
MOC Part IV: Your Guide to Making it Happen. Joseph P. Drozda, Jr., MD, F.A.C.C. Mercy, MO Paul D. Varosy, MD, F.A.C.C., FAHA, FHRS University of Colorado Denver School of Medicine, CO Disclosures Course
More informationRetrospective Chart Review Studies
Retrospective Chart Review Studies Designed to fulfill requirements for real-world evidence Retrospective chart review studies are often needed in the absence of suitable healthcare databases and/or other
More informationThe Veterans Health Administration CART Program: Integration of Real-Time Data Collection into the Process of Clinical Care
The Veterans Health Administration CART Program: Integration of Real-Time Data Collection into the Process of Clinical Care Paul D. Varosy, MD Director of Cardiac Electrophysiology VA Eastern Colorado
More informationVeterans Health Administration: Surveillance of Cardiovascular Disease, Diabetes Mellitus, and Chronic Obstructive Pulmonary Disease
Veterans Health Administration: Surveillance of Cardiovascular Disease, Diabetes Mellitus, and Chronic Obstructive Pulmonary Disease Paul D. Varosy, MD Director of Cardiac Electrophysiology VA Eastern
More informationModernizing Hospital Adverse Event Reporting
Modernizing Hospital Adverse Event Reporting 14 December 2016 Sarah H. Stec Not Legal Advice For Informational and Educational Purposes Only Firm Overview More than 1,500 lawyers in 46 offices across 21
More informationCatherine Porto, MPA, RHIA, CHP Executive Director HIM. Madelyn Horn Noble 3M HIM Data Analyst
1 Catherine Porto, MPA, RHIA, CHP Executive Director HIM Madelyn Horn Noble 3M HIM Data Analyst University of New Mexico Hospitals» The state s only academic medical center» The primary teaching hospital
More informationHow to build a TAVI Team
How to build a TAVI Team TAVI Summit, Seoul, Korea, September 3rd, 2011 Alain Cribier, MD Charles Nicolle Hospital, University of Rouen, France Disclosure Consultant and involved in the Training / Proctoring
More informationTopic: CAP s Legislative Proposal for Laboratory-Developed Tests (LDT) Date: September 14, 2015
Topic: CAP s Legislative Proposal for Laboratory-Developed Tests (LDT) Date: September 14, 2015 1. What are the CAP s views on the regulatory oversight of laboratory-developed tests (LDTs)? 2. How are
More informationSafety Surveillance for Medical Devices
Safety Surveillance for Medical Devices May 10, 2012 James P. Keller, M.S. Vice President, Health Technology Evaluation and Safety jkeller@ecri.org (610) 825-6000, ext. 5279 Presentation Overview ECRI
More informationStrategies to Improve Local and National Cardiac Arrest Data Registries
Strategies to Improve Local and National Cardiac Arrest Data Registries Bryan McNally, MD, MPH Executive Director CARES Associate Professor of Emergency Medicine Emory University School of Medicine Rollins
More informationSTATEMENT. JEFFREY SHUREN, M.D., J.D. Director, Center for Devices and Radiological Health Food and Drug Administration
STATEMENT JEFFREY SHUREN, M.D., J.D. Director, Center for Devices and Radiological Health Food and Drug Administration Institute of Medicine Committee on Patient Safety and Health Information Technology
More informationFaster, More Efficient Innovation through Better Evidence on Real-World Safety and Effectiveness
Faster, More Efficient Innovation through Better Evidence on Real-World Safety and Effectiveness April 28, 2015 l The Brookings Institution Authors Mark B. McClellan, Senior Fellow and Director of the
More informationSaturday, November 15, 2008
The 12 th Annual Meeting of the INDIANA Chapter of the American College of Cardiology Saturday, November 15, 2008 The Columbia Club Indianapolis, IN Jointly Sponsored/Co-Provided by The American College
More informationFocus on Medical Device: A conversation about Case for Quality. September 22, 2017
Focus on Medical Device: A conversation about Case for Quality September 22, 2017 Agenda Welcome and Introductions Why create a Voluntary Program? What is the Voluntary Program? Q&A 2017 Grant Thornton
More informationSame Day Vascular Interventions in an Office or Freestanding Facility: The US Experience
Same Day Vascular Interventions in an Office or Freestanding Facility: The US Experience Jeffrey G. Carr, MD, FACC, FSCAI Founding and Immediate Past President- Outpatient Endovascular and Interventional
More informationGCP Inspection by PMDA
2012 EU GCP Inspectors Working Group Workshop London, 12-14 November 2012 Practical Experience in GCP inspections, non EU/EEA countries GCP Inspection by PMDA Kazuko Natsui Inspector for GCP Inspection,
More informationPragmatic Trial Designs Capturing Endpoints and Integrating Data from Non-Linked Sources
Pragmatic Trial Designs Capturing Endpoints and Integrating Data from Non-Linked Sources Matthew T. Roe, MD, MHS Duke Clinical Research Institute Conflict of Interest Statement Matthew T. Roe, MD, MHS
More informationReal-World Evidence: A CDRH Perspective
Real-World Evidence: A CDRH Perspective Karen Ulisney, MSN, CRNP Policy Analyst, Clinical Trials Program Office of Device Evaluation CDRH, FDA Case for Quality Forum July 20, 2017 Patients are at the Heart
More informationDisruptive Therapies in Congenital Heart Disease: The Right Ventricular Outflow Tract SATURDAY AND SUNDAY, OCT. 28 & 29, :30 A.M. 5:00 P.M.
Disruptive Therapies in Congenital Heart Disease: The Right Ventricular Outflow Tract SATURDAY AND SUNDAY, OCT. 28 & 29, 2017 7:30 A.M. 5:00 P.M. Designed for pediatric and adult cardiologists, cardiac
More informationPennsylvania Patient and Provider Network (P3N)
Pennsylvania Patient and Provider Network (P3N) Cross-Boundary Collaboration and Partnerships Commonwealth of Pennsylvania David Grinberg, Deputy Executive Director 717-214-2273 dgrinberg@pa.gov Project
More informationHarvesting Wearable Device Data Session 230, March 6, 2018 Ajay K. Mittal, Associate Director, IT American College of Cardiology
Harvesting Wearable Device Data Session 230, March 6, 2018 Ajay K. Mittal, Associate Director, IT American College of Cardiology 1 Conflict of Interest Ajay K. Mittal, MS, B. Tech. Has no real or apparent
More informationMedicare / Accountable Care Organization CHS Finance Division CPE Day November 2, 2015
Medicare / Accountable Care Organization CHS Finance Division CPE Day November 2, 2015 Steve Neorr Chief Administrative Officer, Triad HealthCare Network Jeff Jones Chief Financial Officer, Cone Health
More informationPolitical and Legislative Environment
- 2-208 Washington Update Drew Voytal, MPA Associate Director MGMA Government Affairs Agenda Political and legislative environment Federal physician payment landscape Other Trending topics MGMA Advocacy
More informationApps at the Point Of Care
Apps at the Point Of Care Andrew Freeman, MD, FACC Director of Clinical Cardiology and Operations National Jewish Health Associate Professor of Medicine National Jewish Health and University of Colorado
More informationReconciling Abstracted to Electronic Quality Measures
Reconciling Abstracted to Electronic Quality Measures Tuesday, March 1, 2016 Keith F. Woeltje, PhD, MD, VP and Chief Medical Information Officer BJC HealthCare Center for Clinical Excellence Liz Richard,
More informationThe CART Transactional Approach
June 23 rd, 2010 FDA Headquarters The CART Transactional Approach High quality, Prospective Registry Design: Issues and Answers for TREAT Thomas T. Tsai, MD, MSc Director of Interventional Cardiology Clinical
More informationMACRA Frequently Asked Questions
Following the release of the Quality Payment Program Interim Final Rule, the American Medical Association (AMA) conducted numerous informational and training sessions for physicians and medical societies.
More informationPostmarketing Drug Safety and Inspection Readiness
Postmarketing Drug Safety and Inspection Readiness June 19, 2018 Center for Drug Evaluation and Research (CDER) Small Business and Industry Assistance (SBIA) Webinar United States Food and Drug Administration
More informationLatham & Watkins Corporate Department
Number 1133 January 27, 2011 Client Alert Latham & Watkins Corporate Department FDA Announces Actions Designed to Improve the 510(k) Premarket Clearance Process Importantly, however, the Agency s identified
More informationMedicare s Impact on Cardiology Drugs and Devices During Clinical Research
Medicare s Impact on Cardiology Drugs and Devices During Clinical Research Ryan Meade, JD Meade & Roach, LLP July 15, 2008 Baltimore, Maryland University of Maryland School of Medicine 1 Overview Theme:
More informationThe Joint Commission's Performance Measurement Journey
The Joint Commission's Performance Measurement Journey 04/15/2015 Patricia A. Craig Associate Project Director - Division of Healthcare Quality Evaluation The Joint Commission DISCLAIMER: The views and
More informationMDEpiNet RAPID Meeting
MDEpiNet RAPID Meeting BUILD, PCORnet & SENTINEL: Background, Data Model and Data Elements Jeffrey Brown, PhD Associate Professor May 25, 2017 1 FDA Sentinel: Background 2007: FDA Amendments Act A mandate
More informationClinical Operations. Kelvin A. Baggett, M.D., M.P.H., M.B.A. SVP, Clinical Operations & Chief Medical Officer December 10, 2012
Clinical Operations Kelvin A. Baggett, M.D., M.P.H., M.B.A. SVP, Clinical Operations & Chief Medical Officer December 10, 2012 Forward-looking Statements Certain statements contained in this presentation
More informationInternational trend on medical device regulatory convergence
International trend on medical device regulatory convergence Mari Shirotani, Ph.D. Division Director, Office of International Programs Pharmaceuticals and Medical Devices Agency (PMDA) 1st December, 2017
More informationImproving Clinical Outcomes The Case for Electronic ED Door to EKG Time Monitoring
Improving Clinical Outcomes The Case for Electronic ED Door to EKG Time Monitoring 2014 Distinguished Achievement Award for Clinical Excellence TM Competition October 22, 2014 St. Dominic-Jackson Memorial
More informationPLAN OF ACTION FOR IMPLEMENTATION OF 510(K) AND SCIENCE RECOMMENDATIONS
PLAN OF ACTION FOR IMPLEMENTATION OF 510(K) AND SCIENCE RECOMMENDATIONS In August 2010, the Food and Drug Administration s Center for Devices and Radiological Health (CDRH or the Center) released for public
More informationReal World Evidence in Europe
Real World Evidence in Europe Jessamy Baird, RWE Director Madrid, 20 th October 2014. BEFORE I BEGIN; DISCLAIMERS: Dual perspective: Pharmaceutical: I work for Lilly, but this presentation represents my
More informationStatement for the Record. American College of Physicians. Hearing before the House Energy & Commerce Subcommittee on Health
Statement for the Record American College of Physicians Hearing before the House Energy & Commerce Subcommittee on Health A Permanent Solution to the SGR: The Time Is Now January 21-22, 2015 The American
More informationWho is our TAVR population?
The Structural Heart Disease Patient Experience Jennifer Dollery RN, BSN Structural Heart Disease Program Manager The Ohio State University Wexner Medical Center 1 Who is our TAVR population? 2 Early TAVR
More informationGlobal Medical Safety Post-Doctoral Global Medical Safety (GMS) Fellowship
Global Medical Safety Post-Doctoral Global Medical Safety (GMS) Fellowship 2017-2018 Janssen R&D US A Message from the Head of Global Medical Organization At Janssen Pharmaceutical Companies of Johnson
More informationBest Practices for emeasure Implementation. Breakout Session #2: Implementation in Office-Based Practice Settings
Best Practices for emeasure Implementation Breakout Session #2: Implementation in Office-Based Practice Settings Track Leaders: Kendra Hanley John Maese, MD Michael Mirro, MD April 26, 2012 emeasure Learning
More informationManaging Privacy Risk in Your Research and Development Enterprise. Sujata Dayal, Abbott Justin McCarthy, Pfizer
Managing Privacy Risk in Your Research and Development Enterprise Sujata Dayal, Abbott Justin McCarthy, Pfizer Why Privacy Matters Human subject data is extremely sensitive Access to data is critical to
More informationBricks and Mortar of a Telehealth Initiative
Bricks and Mortar of a Telehealth Initiative Session 279, Date of Session: March 8, 2018 Suzanne Richardson, MSN-HCSM, RN Laurie Eccleston, MPA, RN, CPHIMS 1 Conflict of Interest Suzanne E. Richardson,
More informationMaximize the value of CHF population management programs with advanced analytics PLAYBOOK
Maximize the value of CHF population management programs with advanced analytics PLAYBOOK STEP ONE: Analyze your patient population Bend the cost curve: Learning more about your patients can lead to higher-quality
More informationUser Group Meeting. December 2, 2011
User Group Meeting December 2, 2011 1 Agenda 12:00 Welcome Christine Lavoie 12:05 Session Objectives Christine Lavoie 12:10 USC s Research Administration System Christine Lavoie 12:20 Project Overview
More information4.10. Ontario Research Fund. Chapter 4 Section. Background. Follow-up on VFM Section 3.10, 2009 Annual Report. The Ministry of Research and Innovation
Chapter 4 Section 4.10 Ministry of Research and Innovation Ontario Research Fund Follow-up on VFM Section 3.10, 2009 Annual Report Chapter 4 Follow-up Section 4.10 Background The Ontario Research Fund
More informationTHE CANADIAN CARDIOVASCULAR SOCIETY QUALITY INDICATORS E- CATALOGUE QUALITY INDICATORS FOR TRANSCATHETER AORTIC VALVE IMPLANTATION (TAVI)
THE CANADIAN CARDIOVASCULAR SOCIETY QUALITY INDICATORS E- CATALOGUE QUALITY INDICATORS FOR TRANSCATHETER AORTIC VALVE IMPLANTATION (TAVI) A CCS CONSENSUS DOCUMENT FINAL V1 Last updated: September 16, 2015
More information2018 Collaborative Quality Initiative Fact Sheet
2018 Collaborative Quality Initiative Fact Sheet Blue Cross Blue Shield of Michigan Cardiovascular Consortium Overview The Blue Cross Blue Shield of Michigan Cardiovascular Consortium, commonly called
More informationNew Alignments in Data-Driven Care Coordination & Access for Specialty Products: Insights from the DIMENSIONS Report
New Alignments in Data-Driven Care Coordination & Access for Specialty Products: Insights from the DIMENSIONS Report Our Objectives By the end of the session, participants will understand: Evolving demands
More informationFDA s Office of Regulatory Affairs: Violation Trends & Medical Device Update
FDA s Office of Regulatory Affairs: Violation Trends & Medical Device Update Ginger M. Sykes Supervisory Consumer Safety Officer Salt Lake City Resident Post Office of Regulatory Affairs U.S. Food and
More informationFDA Medical Device Regulations vs. ISO 14155
Vol. 11, No. 9, September 2015 Happy Trials to You FDA Medical Device Regulations vs. ISO 14155 By Shawn Kennedy Medical device clinical trials must comply with 21 CFR Parts 11 (Electronic Records), 50
More information5D QAPI from an Operational Approach. Christine M. Osterberg RN BSN Senior Nursing Consultant Pathway Health Pathway Health 2013
5D QAPI from an Operational Approach Christine M. Osterberg RN BSN Senior Nursing Consultant Pathway Health Objectives Review the post-acute care data agenda. Explain QAPI principles Describe leadership
More informationFDA SEATTLE DISTRICT REGULATORY UPDATE
FDA SEATTLE DISTRICT REGULATORY UPDATE SEAFOOD PRODUCTS ASSOCIATION PROCESSORS WORKSHOP SEATTLE, WASHINGTON MARCH 10, 2015 MIRIAM R. BURBACH SEATTLE DISTRICT DIRECTOR 1 FDA SEATTLE DISTRICT REGULATORY
More information2019 AANS Annual Scientific Meeting Abstract Instructions
Visit MyAANS and login. Login Enter in your user ID and password. If you forgot your user ID and/or password, please use the Login Help link. Do not create another account if you cannot remember your password.
More informationAggregating Physician Performance Data Across Health Plans
Aggregating Physician Performance Data Across Health Plans March 2011 A project funded by The Robert Wood Johnson Foundation Measures Included in The Pilot: 1. Breast cancer screening 2. Colorectal cancer
More informationICD-10 Implementation and Medicare Testing. February 26, 2015
ICD-10 Implementation and Medicare Testing February 26, 2015 The Medicare Learning Network This MLN Connects National Provider Call (MLN Connects Call) is part of the Medicare Learning Network (MLN), a
More informationUA Policy on Conflict of Interest/Financial Disclosure in Research and Other Sponsored Programs (revised August 2012) FREQUENTLY ASKED QUESTIONS
1) What is the purpose of the revised UA policy on financial conflict of interest? The revised UA policy stems from recently revised federal regulations (HHS/PHS) designed to promote objectivity in research
More informationDeveloping an Oregon Maternal Data Center: Demo of the California System and Plans for an Oregon Pilot December 2 1:00-3:00pm.
Developing an Oregon Maternal Data Center: Demo of the California System and Plans for an Oregon Pilot December 2 1:00-3:00pm Webinar Housekeeping Notes All lines have been muted. We encourage you to type
More informationN.E.W.T. Level Measurement:
N.E.W.T. Level Measurement: Voldemort or Dumbledore? Nathan Spell, MD, FACP Chief Quality Officer, Emory University Hospital Georgia Chapter Scientific Meeting American College of Physicians Savannah,
More informationUniversal Public Health Node (UPHN): HIE and the Opportunities for Health Information Management
Universal Public Health Node (UPHN): HIE and the Opportunities for Health Information Management - Increasing internal and external value of health information through integration, interoperability, standardization,
More informationICD-10 is Financially Disastrous for Physicians
Kathleen Sebelius Secretary US Department of Health and Human Services Hubert H Humphrey Building, Room 445-G 200 Independence Avenue, SW Washington, DC 20201 Dear Secretary Sebelius: On behalf of the
More informationSUPPORTING DATA QUALITY NJR STRATEGY 2014/16
SUPPORTING DATA QUALITY NJR STRATEGY 2014/16 CONTENTS Supporting data quality 2 Introduction 2 Aim 3 Governance 3 Overview: NJR-healthcare provider responsibilities 3 Understanding current 4 data quality
More informationWorkflow and Usability Improve Immunization-Related Data Quality for Providers and Public Health Session 55, March 6, 2018 Kafayat Adeniyi, Public
Workflow and Usability Improve Immunization-Related Data Quality for Providers and Public Health Session 55, March 6, 2018 Kafayat Adeniyi, Public Health Project Manager, CDC Floyd Eisenberg, VP Quality
More informationDesigning Reliable Value-based Systems of Care for Chronic Disease and Prevention
Designing Reliable Value-based Systems of Care for Chronic Disease and Prevention Frederick J. Bloom, Jr. MD MMM President, Guthrie Medical Group 1/23/15 Where We Want to Be 1. Affordable coverage for
More informationRegulatory Binder Checklist for FDA-Regulated Sponsor/Sponsor-Investigator Studies
Regulatory Binder Checklist for FDA-Regulated Sponsor/Sponsor-Investigator Studies DIRECTIONS: 1. The purpose of a regulatory binder is to assure that all essential elements are maintained in an organized
More informationPotential Measures for the IPFQR Program and the Pre-Rulemaking Process. March 21, 2017
Potential Measures for the IPFQR Program and the Pre-Rulemaking Process March 21, 2017 Speakers Michelle Geppi Health Insurance Specialist Centers for Medicare & Medicaid Services Erin O Rourke Senior
More informationMACRA, MIPS, and APMs What to Expect from all these Acronyms?!
MACRA, MIPS, and APMs What to Expect from all these Acronyms?! ACP Pennsylvania Council Meeting Saturday, December 5, 2015 Shari M. Erickson, MPH Vice President, Governmental Affairs & Medical Practice
More informationCPC+ CHANGE PACKAGE January 2017
CPC+ CHANGE PACKAGE January 2017 Table of Contents CPC+ DRIVER DIAGRAM... 3 CPC+ CHANGE PACKAGE... 4 DRIVER 1: Five Comprehensive Primary Care Functions... 4 FUNCTION 1: Access and Continuity... 4 FUNCTION
More informationMedicare Hospital Inpatient Prospective Payment System for Acute Care Hospitals Final 2016 Rates & Policies 1
Medicare Hospital Inpatient Prospective Payment System for Acute Care Hospitals Final 2016 Rates & Policies 1 Cardiac Rhythm Management (CRM) Market Impacts Introduction On August 3, 2015, the Centers
More informationRE: CMS-1677-P; Medicare Program; Request for Information on CMS Flexibilities and Efficiencies
June 13, 2017 Ms. Seema Verma Administrator Centers for Medicare and Medicaid Services Department of Health and Human Services Attention: CMS-1677-P P.O. Box 8011 Baltimore, MD 21244-1850 RE: CMS-1677-P;
More informationPreparing GI ASCs for October 2012
Preparing GI ASCs for October 2012 Anita J. Bhatia, PHD, MPH, Centers for Medicare and Medicaid Services Lawrence B. Cohen, MD, FACG, AGAF, FASGE, New York Gastroenterology Associates Lawrence R. Kosinski,
More informationTomoko OSAWA, Ph.D. Director for GCP Inspection Office of Conformity Audit PMDA, Japan
Tomoko OSAWA, Ph.D. Director for GCP Inspection Office of Conformity Audit PMDA, Japan The views presented in this presentation are those of the author and should not be understood or quoted as being made
More informationImproving Coordinate Accuracy for Cancer Cases in Oklahoma
Improving Coordinate Accuracy for Cancer Cases in Oklahoma ENVIRONMENTAL PUBLIC HEALTH TRACKING ASTHO FELLOWSHIP REPORT Submitted by Anne Pate, MPH, PhD and Amber Sheikh, MPH Oklahoma State Department
More informationTargeted technology and data management solutions for observational studies
Targeted technology and data management solutions for observational studies August 18th 2016 Zia Haque Arshad Mohammed Copyright 2016 Quintiles Your Presenters Zia Haque Senior Director of Data Management,
More informationPatient Experience of Care
Minnesota Department of Health: Protecting, maintaining and improving the health of all Minnesotans Minnesota Statewide Quality Reporting and Measurement System (SQRMS): Patient Experience of Care March
More informationOrganizational Vitality
AUGS Strategic Plan 2018 Operational Plan Education Research Clinical Practice AUGS promotes the highest quality patient care through excellence in education, research and advocacy Quality 1 Organizational
More informationNovember 7, Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, Room 1061 Rockville, MD 20852
1300 North 17 th Street Suite 1752 Arlington, Virginia 22209 Tel: 703.841.3200 Fax: 703.841.3392 www.medicalimaging.org November 7, 2011 Division of Dockets Management (HFA-305) Food and Drug Administration
More informationTake a Course of Action.
Take a Course of Action. When you choose RAPS Online University, you ll be on track to expand your regulatory knowledge and advance your career. Our comprehensive learning provides an immersive experience
More informationWhat s Next: People-Powered Knowledge Generation from Digital Data
What s Next: People-Powered Knowledge Generation from Digital Data Harlan M. Krumholz, MD Yale University and Yale New Haven Health harlan.krumholz@yale.edu @hmkyale January 13, 2017 Disclosure Founder,
More informationTransitioning to ICD-10. Presented by: The Centers for Medicare & Medicaid Services
Transitioning to ICD-10 Presented by: The Centers for Medicare & Medicaid Services June 20, 2013 ICD-10 Basics ICD-10 Implementation ICD-10 Compliance Date The compliance deadline for ICD-10-CM and PCS
More information